![A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy | BMC Cardiovascular Disorders | Full Text A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-020-01502-4/MediaObjects/12872_2020_1502_Fig1_HTML.png)
A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy | BMC Cardiovascular Disorders | Full Text
![Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - European Journal of Cancer Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/71237f19-809d-4fa5-8f44-dd5e4a6b1c0d/gr1.jpg)
Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - European Journal of Cancer
![Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries | Journal of Hematology & Oncology | Full Text Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1756-8722-7-32/MediaObjects/13045_2014_Article_392_Fig4_HTML.jpg)
Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries | Journal of Hematology & Oncology | Full Text
![Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI. Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/2068155/preview.jpg)
Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI.
![Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive](https://archive.cancerworld.net/wp-content/uploads/2015/10/RCT-of-Letrozole-in-Post-menopausal-breast-cancer.jpg)
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Progression-free survival (PFS), event-free survival (EFS), and overall... | Download Scientific Diagram
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer | PLOS ONE
![Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis](https://www.mdpi.com/cancers/cancers-13-04941/article_deploy/html/images/cancers-13-04941-g001.png)
Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
![Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7b390ded-6c92-4578-8079-4e858709eaf2/ybbmt54468-fig-0001_lrg.jpg)
Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation
![Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1516848414001455:gr5.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR1aFJOKb7qLd+WBf18Ptk/O8dVG5SMqADZji5skBxdmL83IXxo36SddaR63DsSq89mcTB3Hj+ztPQGA6zqULHnBHpT4s9P3G9ZiXVHfJK3hkMt6mGddu7dsrxAXvHUh2DAVXS65CzzQbSvmIJw+LHH0O4cvudJZ1sLq1lL32NJzmn7aCG/A8lqqCCpYSf7gw6Yqtabyu1B9BQu3aUSQbWle/cVVQFMzbA7D0xvmQlEfSn1+4DQxS/Nh1yR4KMO+RokNoQNIIr1UbZEoIivRQdSk)
Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy
![Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram](https://www.researchgate.net/publication/312303406/figure/fig1/AS:625531582177282@1526149759970/Kaplan-Meier-plot-of-event-free-survival-EFS-and-overall-survival-OS-A-EFS-in-all.png)
Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram
![Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma](https://www.frontiersin.org/files/Articles/835389/fonc-12-835389-HTML/image_m/fonc-12-835389-g002.jpg)
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
![OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/Suppl_1/180/F1.large.jpg)
OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases
![Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram](https://www.researchgate.net/publication/339340909/figure/fig4/AS:958472770310157@1605529124751/Event-free-survival-EFS-and-overall-survival-OS-according-to-risk.png)
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
![Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-67147-7/MediaObjects/41598_2020_67147_Fig1_HTML.png)
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports
![Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ecaf029d-bdde-48ff-bec3-78d3aa6f9c00/gr1_lrg.jpg)
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology
![Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points - Annals of Oncology Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c18947f3-69c6-4ade-838d-66a7342e2e33/gr3.jpg)
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points - Annals of Oncology
![Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic](https://d3i71xaburhd42.cloudfront.net/2aa8254fae649d2ab35d92abb79d94fa9d17f39e/4-Figure1-1.png)
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
![Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation | Journal of Clinical Oncology Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2020/jco.2020.38.issue-26/jco.19.03114/20200825/images/large/jco.19.03114t3.jpeg)
Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation | Journal of Clinical Oncology
![Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649711937435X-fx1.jpg)